Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Gavorestat by Applied Therapeutics for Unspecified Metabolic Disorders: Likelihood of Approval
Gavorestat is under clinical development by Applied Therapeutics and currently in Phase III for Unspecified Metabolic Disorders. According to GlobalData,...
Risk adjusted net present value: What is the current valuation of Applied Therapeutics's Gavorestat?
Gavorestat is a small molecule commercialized by Applied Therapeutics, with a leading Pre-Registration program in Galactosemia. According to Globaldata, it...
Risk adjusted net present value: What is the current valuation of Applied Therapeutics's Gavorestat?
Gavorestat is a small molecule commercialized by Applied Therapeutics, with a leading Pre-Registration program in Galactosemia. According to Globaldata, it...